Construction & Real Estate Global On demand · 24-48h

Global Disposable Bone Cement Injection Cannula Market Strategic Research Report

Global Disposable Bone Cement Injection Cannula Market Strat…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Disposable Bone Cement Injection Cannula Market
$1632025
6.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Eight Gauge to Ten Gauge, Eleven Gauge, Twelve Gauge to Thirteen Gauge, Fourteen Gauge to Fifteen Gauge, Others

By Application: Vertebral Augmentation, Bone Tumor Cementoplasty, Trauma Fixation Augmentation, Revision and Defect Filling, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Medtronic, Stryker, DePuy Synthes, Zimmer Biomet, Globus Medical, Merit Medical Systems, ulrich medical, Tecres, Teknimed, SOMATEX Medical Technologies, G21, IZI Medical Products, Shanghai Kinetic Medical, Seawon Meditech, Shandong Dragon Crown Medical, Weigao Orthopaedic Device, Suzhou Aide

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 143 pages
Market size 2025
$163
Million USD
Forecast CAGR
6.5%
2025-2032
Forecast 2032
$253.3
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Disposable Bone Cement Injection Cannula market size is predicted to grow from US$ 163 million in 2025 to US$ 252 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032.

Disposable Bone Cement Injection Cannula is a sterile single use access and delivery cannula that creates a controlled pathway for injecting orthopedic bone cement into bone under imaging guidance, where placement accuracy and time limited cement handling are critical. It is most closely associated with vertebral augmentation workflows and related cementoplasty procedures, and it is valued for predictable penetration, stable anchoring in cancellous bone, and reliable cement flow without clogging during the usable working window.

Upstream supply is built on precision metal tubing, tip grinding and bevel geometry control, radiopaque markers or visibility features where required, high integrity connectors, and sterile barrier packaging that protects lumen cleanliness and dimensional stability. Although stainless steel and polymers are widely available, medical grade cannulas require validated cleanliness, particulate control, sterilization validation, traceability, and process documentation aligned with regulated device quality systems, which raises qualification effort and reduces fast imitation. Downstream demand is concentrated in hospitals and interventional spine centers, and purchasing is typically organized through hospital supply chain teams, group purchasing structures, and regional tender or framework agreements that prioritize compatibility with commonly used cement viscosities, predictable fluoroscopy handling, and consistent supply performance.

In the current market, global production is around 5200 K Units, with an average selling price of about 32 USD per Unit EXW basis. Supplier concentration sits in the middle range, and Top 5 suppliers control approximately 55 percent of global revenue CR5, reflecting advantages in validated procedure ecosystems, established hospital contracting, and broad gauge and tip portfolios. Demand remains strongest in North America and Europe where vertebral augmentation pathways are mature and device standardization is common, while China and the broader Indo Pacific add incremental units as spine intervention capacity expands and more sites adopt repeatable protocols. Over 2025 to 2031, unit demand should be supported by growth in minimally invasive spine intervention, wider use of cement augmentation alongside fixation in osteoporotic bone, and continued oncology driven cementoplasty, while pricing pressure persists as hospitals consolidate suppliers and push kit standardization. Key constraints include regulatory timelines for design or material updates, the need to maintain stable penetration and flow behavior across lots, and scaling sterile production without increasing lumen defects or particulate failures.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Disposable Bone Cement Injection Cannula market?

What factors are driving Disposable Bone Cement Injection Cannula market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Disposable Bone Cement Injection Cannula market opportunities vary by end market size?

How does Disposable Bone Cement Injection Cannula break out by Gauge Size, by Application?

This report presents a comprehensive overview of the global Disposable Bone Cement Injection Cannula market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Gauge Size

  • Eight Gauge to Ten Gauge
  • Eleven Gauge
  • Twelve Gauge to Thirteen Gauge
  • Fourteen Gauge to Fifteen Gauge
  • Others

Segment by Tip Configuration

  • Beveled Tip
  • Diamond Tip
  • Trocar Tip
  • Side Port Tip
  • Multi Port Tip
  • Others

Segment by Pack Format

  • Single Cannula Sterile Pack
  • Cannula with Stylet Set
  • Cannula with Connector Set
  • Procedure Kit Integrated
  • Others

Segment by Application

  • Vertebral Augmentation
  • Bone Tumor Cementoplasty
  • Trauma Fixation Augmentation
  • Revision and Defect Filling
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Disposable Bone Cement Injection Cannula market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Vertebral Augmentation, Bone Tumor Cementoplasty, Trauma Fixation Augmentation evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Disposable Bone Cement Injection Cannula Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$163
2025
Forecast
$253.3
2032
CAGR
6.5%
2025–2032
リージョン
5
global
Key companies
MedtronicStrykerDePuy SynthesZimmer BiometGlobus MedicalMerit Medical Systemsulrich medicalTecres
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Eight Gauge to Ten GaugeEleven GaugeTwelve Gauge to Thirteen GaugeFourteen Gauge to Fifteen GaugeOthers
By Application
Vertebral AugmentationBone Tumor CementoplastyTrauma Fixation AugmentationRevision and Defect FillingOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Eight Gauge to Ten Gauge
  • 3.1.3 Eleven Gauge
  • 3.1.4 Twelve Gauge to Thirteen Gauge
  • 3.1.5 Fourteen Gauge to Fifteen Gauge
  • 3.1.6 Others
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Vertebral Augmentation
  • 4.1.3 Bone Tumor Cementoplasty
  • 4.1.4 Trauma Fixation Augmentation
  • 4.1.5 Revision and Defect Filling
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Medtronic
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Stryker
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 DePuy Synthes
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Zimmer Biomet
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Globus Medical
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Merit Medical Systems
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 ulrich medical
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Tecres
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Teknimed
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 SOMATEX Medical Technologies
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 G21
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 IZI Medical Products
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Shanghai Kinetic Medical
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Seawon Meditech
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Shandong Dragon Crown Medical
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Weigao Orthopaedic Device
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Suzhou Aide
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Disposable Bone Cement Injection Cannula market?
The global Disposable Bone Cement Injection Cannula market is estimated at US$ 163 million in 2025 (base year) and is projected to reach US$ 252 million by 2032.
How fast is the Disposable Bone Cement Injection Cannula market expected to grow?
The market is expected to grow at a CAGR of 6.5% from 2026 to 2032, expanding from US$ 163 million in 2025 to US$ 252 million in 2032, roughly 1.5 times its base-year value.
What does the Disposable Bone Cement Injection Cannula market cover?
Disposable Bone Cement Injection Cannula is a sterile single use access and delivery cannula that creates a controlled pathway for injecting orthopedic bone cement into bone under imaging guidance, where placement accuracy and time limited cement handling are critical. It is most closely associated with vertebral augmentation workflows and related cementoplasty procedures, and it is valued for predictable penetration, stable anchoring in cancellous bone, and reliable cement flow without clogging during the usable working window.
How is the Disposable Bone Cement Injection Cannula market segmented by gauge size?
By gauge size, the market is segmented into Eight Gauge to Ten Gauge, Eleven Gauge, Twelve Gauge to Thirteen Gauge, Fourteen Gauge to Fifteen Gauge and Others.
What are the key applications of Disposable Bone Cement Injection Cannula?
Key applications covered include Vertebral Augmentation, Bone Tumor Cementoplasty, Trauma Fixation Augmentation, Revision and Defect Filling and Others.
Which companies are profiled in the Disposable Bone Cement Injection Cannula market report?
Key players profiled include Medtronic, Stryker, DePuy Synthes, Zimmer Biomet, Globus Medical, Merit Medical Systems, ulrich medical and Tecres, among 17 companies covered in total.
What geographies does the Disposable Bone Cement Injection Cannula market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Disposable Bone Cement Injection Cannula?
Over 2025 to 2031, unit demand should be supported by growth in minimally invasive spine intervention, wider use of cement augmentation alongside fixation in osteoporotic bone, and continued oncology driven cementoplasty, while pricing pressure persists as hospitals consolidate suppliers and push kit standardization.
What are the main risks and barriers in the Disposable Bone Cement Injection Cannula market?
Upstream supply is built on precision metal tubing, tip grinding and bevel geometry control, radiopaque markers or visibility features where required, high integrity connectors, and sterile barrier packaging that protects lumen cleanliness and dimensional stability.
Who should buy the Disposable Bone Cement Injection Cannula market report?
The report is intended for manufacturers and solution providers, distributors and end users in Vertebral Augmentation, Bone Tumor Cementoplasty and Trauma Fixation Augmentation, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Disposable Bone Cement Injection Cannula market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.